Welcome to NeoSan Pharmaceuticals, a new breed of pharmaceutical company. NeoSan's primary responsibility is directed towards helping patients, their families, and physicians by offering products with proven efficacy and safety histories enhanced through new scientific developments. Our focus is on development and commercialization of products with well-known histories, products which will have a significant impact on all patients' lives.

NeoSan Pharmaceuticals is pursuing a new course - a course that is creating a unique tier of pharmaceutical organization. Building on our expertise and passion to offer enhanced products directly into the market, our focus is intentional in its variance from traditional specialty or niche pharmaceutical companies. The foundation of NeoSan is based on the drug development and improvement competencies of our R&D organization, an organization that credits its roots and expertise to the 22 years of experience of our parent company, aaiPharma. Tradition and expertise have been established by aaiPharma's ability to deliver new life to products that have faced marketplace challenges - a focus we call Product Life Cycle Management (PLCM).

NeoSan's building blocks are founded on the scientific aspects of the PLCM approach and our focus is on delivering solutions to patients and physicians. Our product line is centered within key therapeutic areas such as: CNS and Pain Management; Critical Care; Oncology and Immunosuppression; and Cardiology. NeoSan is committed to the delivery of enhanced products and expertise to today's informed consumers.